[Congenital ocular toxoplasmosis--ocular manifestations and prognosis after early diagnosis of infection]. 2005

J G Garweg, and L Kodjikian, and F Peyron, and C Binquet, and J Fleury, and J-D Grange, and C Quantin, and M Wallon
Universitäts-Augenklinik, Inselspital, Bern, Schweiz. justus.garweg@insel.ch

BACKGROUND Congenital toxoplasmosis (CT) is the most frequently encountered congenital infection. The aim of the present review is to report about the long-term outcome of functional and morphological manifestations after an early confirmation of the diagnosis. METHODS We report on a cohort of patients with serologically confirmed CT, born between 1988 and 2001, who were followed up prospectively at a single centre (Institute of Parasitology, Hôpital de la Croix Rousse, University of Lyon). All patients underwent regular ophthalmological, parasitological and paediatric controls on a half-yearly or annual basis. Ocular manifestations were documented and visual acuity was assessed as far as was possible. RESULTS 1,506 seroconversions were diagnosed during pregnancy, and 327 of the live-born offspring were seropositive for CT. At the end of the study period, ocular manifestations occurred in 79 of the children (24 %), and in 7 cases (9 %) they were discovered during the first month of life. In 72 of the patients (91 %), the ocular manifestations developed between 1 and 151 months (median follow-up time: 6.3 +/- 3.7 years; range: 0.5 - 14 years) under medical treatment for the first year of life. At the end of the study period, information regarding visual acuity was available for 66 patients. In 55 of these (83 %), visual acuity was normal in both eyes, and in 11 (17 %), it was reduced below 0.5. In 1 child, both eyes were functionally affected, one severely. CONCLUSIONS CT may not become manifest ocularly until after a decade, which underlines the necessity for long-term ophthalmological monitoring of the infected individuals. In our patients, the prognostic outcome after therapy for the first year of life was better than that reported in the literature. This favourable outcome may serve as a basis for patient counselling.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005858 Germany A country in central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark. The capital is Berlin.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J G Garweg, and L Kodjikian, and F Peyron, and C Binquet, and J Fleury, and J-D Grange, and C Quantin, and M Wallon
October 2020, Scientific reports,
J G Garweg, and L Kodjikian, and F Peyron, and C Binquet, and J Fleury, and J-D Grange, and C Quantin, and M Wallon
April 2010, Eye (London, England),
J G Garweg, and L Kodjikian, and F Peyron, and C Binquet, and J Fleury, and J-D Grange, and C Quantin, and M Wallon
April 2023, Journal francais d'ophtalmologie,
J G Garweg, and L Kodjikian, and F Peyron, and C Binquet, and J Fleury, and J-D Grange, and C Quantin, and M Wallon
September 1957, The Journal of the Florida Medical Association. Florida Medical Association,
J G Garweg, and L Kodjikian, and F Peyron, and C Binquet, and J Fleury, and J-D Grange, and C Quantin, and M Wallon
December 1960, Journal of mental deficiency research,
J G Garweg, and L Kodjikian, and F Peyron, and C Binquet, and J Fleury, and J-D Grange, and C Quantin, and M Wallon
February 1966, Bulletin des societes d'ophtalmologie de France,
J G Garweg, and L Kodjikian, and F Peyron, and C Binquet, and J Fleury, and J-D Grange, and C Quantin, and M Wallon
December 2018, Parasitology international,
J G Garweg, and L Kodjikian, and F Peyron, and C Binquet, and J Fleury, and J-D Grange, and C Quantin, and M Wallon
January 1950, Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology,
J G Garweg, and L Kodjikian, and F Peyron, and C Binquet, and J Fleury, and J-D Grange, and C Quantin, and M Wallon
December 2003, Current opinion in ophthalmology,
J G Garweg, and L Kodjikian, and F Peyron, and C Binquet, and J Fleury, and J-D Grange, and C Quantin, and M Wallon
November 1958, Strasbourg medical,
Copied contents to your clipboard!